Skip to main content
Year archive

EyeGene,Inc — 2020 filings

All 28 regulatory filings released by EyeGene,Inc (185490) in 2020, sourced directly from the official regulator.

28 Filings
2020 Period
2020 filings (28)
Filing Released Lang
신주인수권행사가액의조정
Share Issue/Capital Change
2020-12-18 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2020-12-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2020-12-03 Korean
기타경영사항(특허권취득)(자율공시)
Investor Presentation
2020-11-24 Korean
분기보고서 (2020.09)
Interim / Quarterly Report 9M 2020
2020-11-16 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update
2020-10-23 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update
2020-09-28 Korean
증권발행결과(자율공시)
Capital/Financing Update
2020-09-18 Korean
주요사항보고서(신주인수권부사채권발행결정)
Capital/Financing Update
2020-09-16 Korean
반기보고서 (2020.06)
Interim / Quarterly Report H1 2020
2020-08-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2020-08-07 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2020-08-03 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2020-07-31 Korean
분기보고서 (2020.03)
Interim / Quarterly Report Q1 2020
2020-05-15 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update
2020-04-24 Korean
사업보고서 (2019.12)
Audit Report / Information FY 2019
2020-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2020-03-27 Korean
감사보고서제출
Audit Report / Information FY 2019
2020-03-17 Korean
주주총회소집공고
AGM Information
2020-03-12 Korean
투자판단관련주요경영사항(당뇨망막증치료제 ‘EG-Mirotin' 국내 임상 제2상 시험계획 승인)
Legal Proceedings Report
2020-03-12 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2020-03-10 Korean
주주총회집중일개최사유신고
Regulatory Filings
2020-03-10 Korean
기타경영사항(특허권취득)(자율공시)(면역반응 조절물질을 포함하는 백신 조성물 및 이의 용도)
Investor Presentation
2020-03-05 Korean
기타경영사항(특허권취득)(자율공시)(양이온성 리포좀을 포함하는 바리셀라 조스터 바이러스 백신 조성물 및 이의 용도 외 1건)
Regulatory Filings
2020-03-05 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports
2020-02-24 Korean
투자판단관련주요경영사항(욕창치료제 'EG-Decorin' 임상1/2상 시험 완료 )
Regulatory Filings
2020-02-12 Korean
투자판단관련주요경영사항(당뇨망막증치료제'EG-Mirotin' 임상2a상 시험 완료)
Regulatory Filings
2020-02-12 Korean
기업설명회(IR)개최
Regulatory Filings
2020-02-11 Korean